Inhibition of MIR-200c restores Endothelial function in diabetic mice through suppression of COX-2

Diabetes

Volumn 65, Issue 5, 2016, Pages 1196-1207

  Zhang, Huina ^a,b,c   Liu, Jian ^a   Qu, Dan ^a   Wang, Li ^a   Luo, Jiang Yun ^a   Lau, Chi Wai ^a   Liu, Pingsheng ^c   Gao, Zhen ^a   Tipoe, George L ^d   Lee, Hung Kay ^a   Ng, Chi Fai ^a   Ma, Ronald Ching Wan ^a   Yao, Xiaoqiang ^a   Huang, Yu ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c INSTITUTE OF BIOPHYSICS   (China)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CYCLOOXYGENASE 2; GLUCOSE; INSULIN; MICRORNA 200C; MICRORNA 200C ANTIBODY; PROSTAGLANDIN E2; RNA ANTIBODY; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG; MICRORNA; MIRN200 MICRORNA, HUMAN; MIRN200 MICRORNA, MOUSE; PTGS2 PROTEIN, HUMAN; PTGS2 PROTEIN, MOUSE; RNA; RNA, RECOMBINANT;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME REPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INSULIN TOLERANCE TEST; MIDDLE AGED; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; UPREGULATION; VASODILATATION; VIRAL GENE DELIVERY SYSTEM; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; CELL LINE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; IN VITRO STUDY; KIDNEY ARTERY; KNOCKOUT MOUSE; METABOLISM; MUTANT MOUSE STRAIN; PATHOLOGY; PATHOPHYSIOLOGY; RNA INTERFERENCE; THORACIC AORTA; VASCULAR ENDOTHELIUM;

ADULT; AGED; ANIMALS; AORTA, THORACIC; CELL LINE; CELLS, CULTURED; CYCLOOXYGENASE 2; DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; IN VITRO TECHNIQUES; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MICRORNAS; MIDDLE AGED; RENAL ARTERY; RNA; RNA INTERFERENCE; VASODILATION; ZINC FINGER E-BOX-BINDING HOMEOBOX 1;

EID: 84964655373     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db15-1067     Document Type: Article

References (43)

1. Danaei G, Finucane MM, Lu Y, et al.; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2$7 million participants. Lancet 2011;378:31-40
2. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-1431
3. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999;100:1134-1146
4. Spinetti G, Kraenkel N, Emanueli C, Madeddu P. Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies. Cardiovasc Res 2008;78:265-273
5. Tesfamariam B, Brown ML, Cohen RA. Elevated glucose impairs endotheliumdependent relaxation by activating protein kinase C. J Clin Invest 1991;87:1643-1648
6. Williams SB, Goldfine AB, Timimi FK, et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 1998;97:1695-1701
7. Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol 2007;23:175-205
8. Urbich C, Kuehbacher A, Dimmeler S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 2008;79:581-588
9. Ji R, Cheng Y, Yue J, et al. MicroRNA expression signature and antisensemediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ Res 2007;100:1579-1588
10. Leeper NJ, Raiesdana A, Kojima Y, et al. MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol 2011;226:1035-1043
11. Fang Y, Shi C, Manduchi E, Civelek M, Davies PF. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc Natl Acad Sci U S A 2010;107:13450-13455
12. Zhang Y, Qin W, Zhang L, et al. MicroRNA-26a prevents endothelial cell apoptosis by directly targeting TRPC6 in the setting of atherosclerosis. Sci Rep 2015;5:9401
13. McArthur K, Feng B, Wu Y, Chen S, Chakrabarti S. MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy. Diabetes 2011;60:1314-1323
14. Reddy MA, Jin W, Villeneuve L, et al. Pro-inflammatory role of microRNA-200 in vascular smooth muscle cells from diabetic mice. Arterioscler Thromb Vasc Biol 2012;32:721-729
15. Kato M, Arce L, Wang M, Putta S, Lanting L, Natarajan R. A microRNA circuit mediates transforming growth factor-b1 autoregulation in renal glomerular mesangial cells. Kidney Int 2011;80:358-368
16. Wong WT, Tian XY, Xu A, et al. Adiponectin is required for PPARg-mediated improvement of endothelial function in diabetic mice. Cell Metab 2011;14:104-115
17. Tian XY, Wong WT, Xu A, et al. Uncoupling protein-2 protects endothelial function in diet-induced obese mice. Circ Res 2012;110:1211-1216
18. Chan YC, Leung FP, Wong WT, et al. Therapeutically relevant concentrations of raloxifene dilate pressurized rat resistance arteries via calcium-dependent endothelial nitric oxide synthase activation. Arterioscler Thromb Vasc Biol 2010;30:992-999
19. Luo J, Deng ZL, Luo X, et al. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2007;2:1236-1247
20. Marquart TJ, Allen RM, Ory DS, Baldán A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci U S A 2010;107:12228-12232
21. Wong SL, Leung FP, Lau CW, et al. Cyclooxygenase-2-derived prostaglandin F2alpha mediates endothelium-dependent contractions in the aortae of hamsters with increased impact during aging. Circ Res 2009;104:228-235
22. Burk U, Schubert J, Wellner U, et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 2008;9:582-589
23. Bagi Z, Erdei N, Toth A, et al. Type 2 diabetic mice have increased arteriolar tone and blood pressure: enhanced release of COX-2-derived constrictor prostaglandins. Arterioscler Thromb Vasc Biol 2005;25:1610-1616
24. Tian XY, Wong WT, Leung FP, et al. Oxidative stress-dependent cyclooxygenase-2-derived prostaglandin f (2a) impairs endothelial function in renovascular hypertensive rats. Antioxid Redox Signal 2012;16:363-373
25. Wong WT, Tian XY, Chen Y, et al. Bone morphogenic protein-4 impairs endothelial function through oxidative stress-dependent cyclooxygenase-2 upregulation: implications on hypertension. Circ Res 2010;107:984-991
26. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005;120:15-20
27. Lau YS, Tian XY, Mustafa MR, et al. Boldine improves endothelial function in diabetic db/db mice through inhibition of angiotensin II-mediated BMP4-oxidative stress cascade. Br J Pharmacol 2013;170:1190-1198
28. Magenta A, Cencioni C, Fasanaro P, et al. miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Cell Death Differ 2011;18:1628-1639
29. Wellner U, Schubert J, Burk UC, et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 2009;11:1487-1495
30. Schliekelman MJ, Gibbons DL, Faca VM, et al. Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. Cancer Res 2011;71:7670-7682
31. Bracken CP, Gregory PA, Kolesnikoff N, et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelialmesenchymal transition. Cancer Res 2008;68:7846-7854
32. Pannirselvam M, Wiehler WB, Anderson T, Triggle CR. Enhanced vascular reactivity of small mesenteric arteries from diabetic mice is associated with enhanced oxidative stress and cyclooxygenase products. Br J Pharmacol 2005;144:953-960
33. Cosentino F, Eto M, De Paolis P, et al. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation 2003;107:1017-1023
34. Shanmugam N, Gaw Gonzalo IT, Natarajan R. Molecular mechanisms of high glucose-induced cyclooxygenase-2 expression in monocytes. Diabetes 2004;53:795-802
35. Sheu ML, Ho FM, Yang RS, et al. High glucose induces human endothelial cell apoptosis through a phosphoinositide 3-kinase-regulated cyclooxygenase-2 pathway. Arterioscler Thromb Vasc Biol 2005;25:539-545
36. Dong YJ, Jones RL, Wilson NH. Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues. Br J Pharmacol 1986;87:97-107
37. Chen L, Miao Y, Zhang Y, et al. Inactivation of the E-prostanoid 3 receptor attenuates the angiotensin II pressor response via decreasing arterial contractility. Arterioscler Thromb Vasc Biol 2012;32:3024-3032
38. Félétou M, Verbeuren TJ, Vanhoutte PM. Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors. Br J Pharmacol 2009;156:563-574
39. Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA; American Heart Association. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 2007;115:1634-1642
40. Patrono C, Baigent C. Nonsteroidal anti-inflammatory drugs and the heart. Circulation 2014;129:907-916
41. Rocca B, Secchiero P, Ciabattoni G, et al. Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets. Proc Natl Acad Sci U S A 2002;99:7634-7639
42. Topper JN, Cai J, Falb D, Gimbrone MA Jr. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci U S A 1996;93:10417-10422
43. Yu Y, Ricciotti E, Scalia R, et al. Vascular COX-2 modulates blood pressure and thrombosis in mice. Sci Transl Med 2012;4:132ra54